P3 Health Partners (PIII) vs Starling Oncology (STLN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Starling Oncology (STLN) has outperformed P3 Health Partners (PIII) over the past year, gaining 68.3% versus a loss of 37.6%. Over five years, STLN leads with a -35.4% price change compared with -98.9% for PIII. P3 Health Partners is the larger company by market cap ($1.12 billion vs $631.4 million), about 1.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PIII | STLN |
|---|---|---|
| Share price | $5.50 | $6.20 |
| Market cap | $1.12B | $631.37M |
| 1-day change | -2.31% | -3.65% |
| YTD return | +61.32% | +80.62% |
| 1-year return | -37.56% | +68.32% |
| 5-year return | -98.87% | -35.38% |
| EPS (TTM) | $-33.02 | $-0.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.89 | $7.13 |
| 52-week low | $1.52 | $2.32 |
| Distance from 52-week high | -67.44% | -13.11% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +227.27% | +45.28% |
| Average volume | 32.65K | 1.54M |
| Shares outstanding | 3.91M | 101.92M |
| Employees | 320 | 641 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- STLN has outperformed PIII by 105.9 percentage points over the past year.
About P3 Health Partners
PIII stock →P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers.
Health Care · Medical/Nursing Services · 320 employees
About Starling Oncology
STLN stock →Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.
Health Care · Medical/Nursing Services · 641 employees
PIII vs STLN FAQ
Which is bigger, P3 Health Partners or Starling Oncology?
P3 Health Partners (PIII) is larger, with a market capitalization of $1.12B compared with $631.37M for Starling Oncology (STLN).
Which stock has performed better over the past year, PIII or STLN?
STLN returned +68.32% over the past 12 months, compared with -37.56% for PIII (price return, excluding dividends). Past performance does not predict future results.
Are P3 Health Partners and Starling Oncology in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.